Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

The Evolution of Quality by Design (QbD) for Biologics

Anthony R. Newcombe
PDA Journal of Pharmaceutical Science and Technology July 2014, 68 (4) 320-322; DOI: https://doi.org/10.5731/pdajpst.2014.00989
Anthony R. Newcombe
Principal Consultant, PAREXEL International, Uxbridge, Middlesex, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anthony.newcombe@parexel.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 68 no. 4 320-322
DOI 
https://doi.org/10.5731/pdajpst.2014.00989
PubMed 
25035254

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online July 17, 2014.

Copyright & Usage 
© PDA, Inc. 2014

Author Information

  1. Anthony R. Newcombe*
  1. Principal Consultant, PAREXEL International, Uxbridge, Middlesex, UK
  1. ↵*Corresponding Author: email: anthony.newcombe{at}parexel.com. Telephone: +44 1895614116
View Full Text

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Quality by Design Coupled with Near Infrared in Formulation of Transdermal Glimepiride Liposomal Films
    Osama Abdelhakim Aly Ahmed, Mallesh Kurakula, Zainy Mohamed Banjar, Mohsen Ibrahim Afouna, Ahmed Samir Zidan
    Journal of Pharmaceutical Sciences 2015 104 6
  • Novel calibration design improves knowledge transfer across products for the characterization of pharmaceutical bioprocesses
    Laura M. Helleckes, Claus Wirnsperger, Jakub Polak, Gonzalo Guillén‐Gosálbez, Alessandro Butté, Moritz von Stosch
    Biotechnology Journal 2024 19 7
  • SWATH-MS insights on sodium butyrate effect on mAbs production and redox homeostasis in CHO cells
    Mauro Galli, Lillian Chia-Yi Liu, Kae Hwan Sim, Yee Jiun Kok, Katherine Wongtrakul-Kish, Terry Nguyen-Khuong, Stephen Tate, Xuezhi Bi
    AMB Express 2024 14 1
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 68 (4)
PDA Journal of Pharmaceutical Science and Technology
Vol. 68, Issue 4
July/August 2014
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Evolution of Quality by Design (QbD) for Biologics
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Evolution of Quality by Design (QbD) for Biologics
Anthony R. Newcombe
PDA Journal of Pharmaceutical Science and Technology Jul 2014, 68 (4) 320-322; DOI: 10.5731/pdajpst.2014.00989

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Evolution of Quality by Design (QbD) for Biologics
Anthony R. Newcombe
PDA Journal of Pharmaceutical Science and Technology Jul 2014, 68 (4) 320-322; DOI: 10.5731/pdajpst.2014.00989
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Integration of Regulatory Guidelines into Protein Drug Product Development
  • Google Scholar

More in this TOC Section

  • A Risk Based Approach for Pre-Use/Post-Sterilization Integrity Test Simulation During Bacterial Retention Testing as Part of the Process Specific Filter Validation of Sterilizing Grade Filters
  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
Show more Commentary

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire